EARLY CLINICAL IMPROVEMENTS (WEEK 4) PREDICT SUBSEQUENT CLINICAL RESPONSE WITH IXEKIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNF INHIBITORS Xie, L., Genovese, M. C., Zhu, B., Edson-Heredia, E., Banerjee, S. BMJ PUBLISHING GROUP. 2013: 628

View details for Web of Science ID 000331587903628